Home > News > Cell Genesys: The Promise of GVAX
May 7th, 2007
Cell Genesys: The Promise of GVAX
Abstract:
In recent years, there have been some great improvements in the field of cancer therapy thanks to early diagnosis and new forms of therapies, such as monoclonal antibodies and nanoparticle-coated compounds. For over two decades, cancer vaccines have demonstrated impressive results in early pre-clinical trials, which gave rise to great expectations within the scientific community. Unfortunately, scientists couldn't replicate the early phase success into clinical trials, but there are finally some encouraging signs . With several promising candidates which are currently being evaluated in clinical trials, the cancer vaccine field might become the next big thing in cancer therapy.
Source:
biotech.seekingalpha.com
Bookmark:
Nanomedicine
Nano-needles for cells May 25th, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013
Single-Cell Transfection Tool Enables Added Control for Biological Studies: McCormick researchers develop method of delivering molecules into targeted cells May 22nd, 2013
How Gold Nanoparticles Can Help Fight Ovarian Cancer May 21st, 2013
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals
Heinrich Rohrer dies at 79; a father of nanotechnology: With IBM colleague Gerd Binnig, Rohrer invented the scanning tunneling microscope, which can show individual atoms on a surface and move them around May 23rd, 2013
IDTechEx launches online Market Intelligence Portal May 23rd, 2013
Whirlpools on the Nanoscale Could Multiply Magnetic Memory: At the Advanced Light Source, Berkeley Lab scientists join an international team to control spin orientation in magnetic nanodisks May 22nd, 2013
UofL scientists uncover how grapefruits provide a secret weapon in medical drug delivery May 22nd, 2013